Xevinapant Plus Avelumab in Patients (pts) with Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC): Phase 1b Dose-Expansion Results and Exploratory Biomarker Analyses
CANCER RESEARCH(2023)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined